BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15779425)

  • 1. [The Study TO Prevent Non-Insulin Dependent Diabetes Mellitus trial (acarbose)].
    Nishimura R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():478-82. PubMed ID: 15779425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Sakamoto N; Tajima N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 4. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA
    Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
    [No Abstract]   [Full Text] [Related]  

  • 5. Acarbose feeding increases pancreatic islet blood flow in obese glucose-intolerant Otsuka Long-Evans Tokushima fatty rats.
    Iwase M; Imoto H; Oku M; Shibata S; Sonoki K; Iida M
    Pancreas; 2008 Aug; 37(2):228-30. PubMed ID: 18665092
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acarbose in patients with beta-thalassaemia major and abnormal glucose homeostasis.
    Mangiagli A; Campisi S; De Sanctis V; Nicoletti MC; Cardinale G; Galati MC; Raiola G; Rigano P; Saviano A;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():276-8. PubMed ID: 16462708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NAVIGATOR trial (nateglinide)].
    Tsujii S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():483-7. PubMed ID: 15779426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetes prevention program (metformin)].
    Kusaka I; Nagasaka S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():471-7. PubMed ID: 15779424
    [No Abstract]   [Full Text] [Related]  

  • 10. [Selection of oral antidiabetic drugs].
    Iwamoto Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():428-32. PubMed ID: 15779417
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
    Zeymer U
    Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acarbose: oral anti-diabetes drug with additional cardiovascular benefits.
    Hanefeld M; Schaper F
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):153-63. PubMed ID: 18248270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment for patients with impaired glucose tolerance].
    Tawaramoto K; Kaku K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
    García de los Ríos M; Mujica V; Muñoz S; Durruty P; Larenas G; López MI; Kuzmanic A; Pérez J; Flaskamp R; Cumsille F
    Rev Med Chil; 1997 Aug; 125(8):856-62. PubMed ID: 9580485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study with alpha-glucosidase inhibitor proves: diabetes can be delayed].
    MMW Fortschr Med; 2002 Aug; 144(33-34):57. PubMed ID: 12380153
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of acarbose for the management of impaired glucose tolerance in Sweden.
    Quilici S; Chancellor J; Maclaine G; McGuire A; Andersson D; Chiasson JL
    Int J Clin Pract; 2005 Oct; 59(10):1143-52. PubMed ID: 16178980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristic of metformin for treatment of impaired glucose tolerance].
    Ishida W; Satoh J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
    [No Abstract]   [Full Text] [Related]  

  • 18. [In high risk for diabetes should drugs be used for prevention? (interview by Dr. Judith Neumaier)].
    Hanefeld M
    MMW Fortschr Med; 2002 Oct; 144(40):12. PubMed ID: 12440285
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alpha glucosidase inhibitor].
    Katsuta H; Ishida H
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():637-45. PubMed ID: 17458296
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary prevention of diabetes mellitus by pharmacological intervention].
    Noda M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.